The literature reports conflicting results for survival after extracorporeal membrane oxygenator support, and survival differs in pediatric and adult patients. We present our institutional experience of adult extracorporeal membrane oxygenator support.
Methods:
From January 2007 to December 2009, 19 adult patients required extracorporeal membrane oxygenator support after cardiac surgery or catheter interventions. It was provided on an emergency basis to 11 patients, urgently to 5, and electively to 3. Indications included post-cardiotomy cardiogenic shock, post-cardiotomy acute respiratory failure, emergency cardiac resuscitation, and post-percutaneous coronary intervention cardiogenic shock. The mean duration of support was 4 days (range, 1–11 days).
Results:
Seven (36.84%) patients could be weaned off extracorporeal membrane oxygenator support; one (14.28%) of them survived to hospital discharge and the other 6 (85.71%) died in hospital. Twelve (63.15%) patients could not be weaned off and died while still on extracorporeal membrane oxygenator support. Overall 30-day hospital mortality was 94.73%, and survival to discharge was 5.26%.
Conclusion:
Our institutional experience of extracorporeal membrane oxygenator support for cardiac indications in adult patients indicates poor survival. It significantly increased costs by delaying imminent death and prolonging stay in the intensive care unit.
MagovernGJJrSimpsonKA. Extracorporeal membrane oxygenation for adult cardiac support: the Allegheny experience. Ann Thorac Surg1999; 68: 655–661.
2.
AlsoufiBAl-RadiOONazerRIGruenwaldCForemanCWilliamsWG. Survival outcomes after rescue extracorporeal cardiopulmonary resuscitation in pediatric patients with refractory cardiac arrest. J Thorac Cardiovasc Surg2007; 134: 952–9.e2.
3.
ThiagarajanRRLaussenPCRycusPTBartlettRHBrattonSL. Extracorporeal membrane oxygenation to aid cardiopulmonary resuscitation in infants and children. Circulation2007; 116: 1693–1700.
4.
ChalwinRPMoranJLGrahamPL. The role of extracorporeal membrane oxygenation for treatment of the adult respiratory distress syndrome: review and quantitative analysis [Review]. Anaesth Intensive Care2008; 36: 152–161.
5.
KoWJLinCYChenRJWangSSLinFYChenYS. Extracorporeal membrane oxygenation support for adult postcardiotomy cardiogenic shock. Ann Thorac Surg2002; 73: 538–545.
6.
ConradSARycusPTDaltonH. Extracorporeal Life Support Registry Report 2004. ASAIO J2005; 51: 4–10.
7.
FiserSMTribbleCGKazaAKLongSMZacourRKKernJA. When to discontinue extracorporeal membrane oxygenation for postcardiotomy support. Ann Thorac Surg2001; 71: 210–214.
8.
KawahitoKInoTAdachiHIdeHMizuharaAYamaguciA. Heparin coated percutaneous cardiopulmonary support for the treatment of circulatory collapse after cardiac surgery. ASAIO J1994; 40: 972–976.
9.
SmithCBellomoRRamanJSMatalanisGRosalionABuckmasterJ. An extracorporeal membrane oxygenation-based approach to cardiogenic shock in an older population. Ann Thorac Surg2001; 71: 1421–1427.
10.
WangJHanJJiaYZengWShiJHouX. Early and intermediate results of rescue extracorporeal membrane oxygenation in adult cardiogenic shock. Ann Thorac Surg2009; 88: 1897–1903.
11.
HsuPSChenJLHongGJTsaiYTLinCYLeeCY. Extracorporeal membrane oxygenation for refractory cardiogenic shock after cardiac surgery: predictors of early mortality and outcome from 51 adult patients. Eur J Cardiothorac Surg2010; 37: 328–333.
12.
AlsoufiBAl-RadiOOGruenwaldCLeanLWilliamsWGMcCrindleBW. Extra-corporeal life support following cardiac surgery in children: analysis of risk factors and survival in a single institution. Eur J Cardiothorac Surg2009; 35: 1004–1011.
13.
RastanAJDegeAMohrMDollNFalkVWaltherT. Early and late outcomes of 517 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock. J Thorac Cardiovasc Surg2010; 139: 302–11, 311.e1.
14.
BakhtiaryFKellerHDoganSDzemaliOOezaslanFMeiningerD. Venoarterial extracorporeal membrane oxygenation for treatment of cardiogenic shock: clinical experiences in 45 adult patients. J Thorac Cardiovasc Surg2008; 135: 382–388.
15.
SongSWYangHSLeeSYounYNYooKJ. Earlier application of percutaneous cardiopulmonary support rescues patients from severe cardiopulmonary failure using the APACHE III scoring system. J Korean Med Sci2009; 24: 1064–1070.
16.
SmediraNGMoazamiNGoldingCMMcCarthyPMApperson-HansenCBlackstoneEH. Clinical experience with 202 adults receiving extracorporeal membrane oxygenation for cardiac failure: survival at five years. J Thorac Cardiovasc Surg2001; 122: 92–102.
17.
ChungESLimCLeeHYChoiJHLeeJSParkKH. Results of extracorporeal membrane oxygenation (ECMO) support before coronary reperfusion in cardiogenic shock with acute myocardial infarction. Korean J Thorac Cardiovasc Surg2011; 44: 273–278.
HsuPSChenJLHongGJTsaiYTLinCYLeeCY. Extracorporeal membrane oxygenation for refractory cardiogenic shock after cardiac surgery: predictors of early mortality and outcome from 51 adult patients. Eur J Cardiothorac Surg2010; 37: 328–333.
DollNKiaiiBBorgerMBuceriusJKramerKSchmittDV. Five-year results of 219 consecutive patients treated with extracorporeal membrane oxygenation for refractory postoperative cardiogenic shock. Ann Thorac Surg2004; 77: 151–157.
23.
Xin-jinLuoWeiWangSheng-shouHuHan-songSunHua-weiGaoCunLong. Extracorporeal membrane oxygenation for treatment of cardiac failure in adult patients. Interact Cardiovasc Thorac Surg2009; 9: 296–300.
24.
WermeltJZHonjoOKilicAvan ArsdellGGruenwaldCHumplT. Use of a pulsatile ventricular assist device (Berlin Heart EXCOR) and an interventional lung assist device (Novalung) in an animal model. ASAIO J2008; 54: 498–503.
